|
|
| | Eupalinolide I Basic information |
| Product Name: | Eupalinolide I | | Synonyms: | Eupalinolide I;2-Butenoic acid, 4-hydroxy-2-methyl-, (3aR,4R,6Z,9R,10Z,11aR)-9-(acetyloxy)-6-[(acetyloxy)methyl]-2,3,3a,4,5,8,9,11a-octahydro-10-methyl-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, (2E)- | | CAS: | 1402067-84-8 | | MF: | C24H30O9 | | MW: | 462.49 | | EINECS: | | | Product Categories: | | | Mol File: | 1402067-84-8.mol |  |
| | Eupalinolide I Chemical Properties |
| Boiling point | 618.6±55.0 °C(Predicted) | | density | 1.24±0.1 g/cm3(Predicted) | | pka | 13.68±0.10(Predicted) |
| | Eupalinolide I Usage And Synthesis |
| Uses | Eupalinolide I inhibits the viability of breast cancer cells. Eupalinolide I can be isolated from Eupatorium lindleyanum[1]. | | References | [1] Yang B, et al. Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer. Nat Prod Res. 2019 Feb;33(4):477-485. DOI:10.1080/14786419.2017.1396596 |
| | Eupalinolide I Preparation Products And Raw materials |
|